Clinitech Laboratory Ltd vs Metropolis Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Clinitech Laboratory Ltd is ₹ 30 as of 30 Oct 15:30 . The P/E Ratio of Clinitech Laboratory Ltd changed from 23.3 on March 2025 to 19.1 on March 2026 . This represents a CAGR of -9.46% over 2 yearsThe P/E Ratio of Metropolis Healthcare Ltd changed from 62.6 on March 2021 to 47.3 on March 2026 . This represents a CAGR of -4.56% over 6 years The Market Cap of Clinitech Laboratory Ltd changed from ₹ 9.18 crore on March 2025 to ₹ 7.99 crore on March 2026 . This represents a CAGR of -6.71% over 2 yearsThe Market Cap of Metropolis Healthcare Ltd changed from ₹ 11455 crore on March 2021 to ₹ 8992 crore on March 2026 . This represents a CAGR of -3.95% over 6 years The revenue of Clinitech Laboratory Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Metropolis Healthcare Ltd for the Jun '26 is ₹ 455.32 crore as compare to the Mar '26 revenue of ₹ 432.95 crore. This represent the growth of 5.17% The ebitda of Clinitech Laboratory Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Metropolis Healthcare Ltd for the Jun '26 is ₹ 116.3 crore as compare to the Mar '26 ebitda of ₹ 116.29 crore. This represent the growth of 0.01% The net profit of Clinitech Laboratory Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Metropolis Healthcare Ltd changed from ₹ 38.11 crore to ₹ 56.88 crore over 9 quarters. This represents a CAGR of 19.48% The Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Metropolis Healthcare Ltd changed from 20.69 % on March 2021 to 65.83 % on March 2026 . This represents a CAGR of 21.28% over 6 years .

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

About Metropolis Healthcare Ltd

Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners.
The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards.
In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr. Sushil Kanubhai Shah and Dr. Duru Sushil Shah.
Prior to March 18, 1995, Dr. Sushil Kanubhai Shah was also carrying on a business of radioimmunoassay and pathology laboratory on a sole proprietorship basis.
On March 20, 1995, the said sole proprietorship business was converted into a partnership with Dr. Sushil Kanubhai Shah, Dr.

FAQs for the comparison of Clinitech Laboratory Ltd and Metropolis Healthcare Ltd

Which company has a larger market capitalization, Clinitech Laboratory Ltd or Metropolis Healthcare Ltd?

Market cap of Clinitech Laboratory Ltd is 6 Cr while Market cap of Metropolis Healthcare Ltd is 11,309 Cr

What are the key factors driving the stock performance of Clinitech Laboratory Ltd and Metropolis Healthcare Ltd?

The stock performance of Clinitech Laboratory Ltd and Metropolis Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Clinitech Laboratory Ltd and Metropolis Healthcare Ltd?

As of November 1, 2026, the Clinitech Laboratory Ltd stock price is INR ₹30.0. On the other hand, Metropolis Healthcare Ltd stock price is INR ₹545.15.

How do dividend payouts of Clinitech Laboratory Ltd and Metropolis Healthcare Ltd compare?

To compare the dividend payouts of Clinitech Laboratory Ltd and Metropolis Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.